Research note
Understanding Peptide Lot and Batch Documentation
A lot number is the least interesting field on a vial label and the one that decides whether a result can be defended two years later. It is the identifier that connects a measurement to a specific quantity of material and to the documents that describe it.
Published
Lot, batch, and what each identifies
A batch is conventionally the quantity produced in one manufacturing operation. A lot is a quantity treated as uniform for record-keeping purposes — often a batch, sometimes a subdivision of one, occasionally a defined combination. In commercial peptide supply the terms are used interchangeably often enough that the distinction is not worth defending; what matters is that the number identifies a specific quantity of material that was handled together.
The unit of uniformity is the useful idea. Material within a lot is presumed to be equivalent; material in different lots is not, however identical the product name. Two lots of the same compound may differ in purity, impurity profile, counterion content and water content, all within specification.
Why documentation belongs to the lot
A certificate of analysis reports measurements made on a sample from a specific lot on a specific date. Presented as a property of the product line, it becomes an assertion about material it was never run against.
This distinction is not academic. A supplier who publishes one certificate per compound and ships whatever lot is in the warehouse is presenting a document that does not describe the vial you received. The only way to know a certificate describes your material is for the lot number on the document to match the lot number on the vial.
In our catalog, documentation is attached to the lot in the data model itself, so it cannot be presented any other way. Each product page names the lot currently supplied and shows the documents attached to that lot, and where none are attached it says so rather than showing a document from elsewhere.
What a lot number should let you do
Retrieve the analytical documentation for the material you actually hold.
Establish when it was received and what it was received as.
Identify every experiment performed with it, if the lot number was recorded — and identify none of them, if it was not.
Determine whether an anomalous result is confined to one lot, which is the first question worth asking when a repeat fails and nothing else has changed.
Recording it on your side
Record the lot number at the point of first use, alongside the compound name and the date. This takes seconds and is not reconstructible later — a freezer box of unlabelled aliquots dated by memory is a common and entirely avoidable state of affairs.
Where material is aliquoted, carry the lot number onto the aliquots. Where a result is written up, cite the lot alongside the supplier and the compound. A methods section naming a supplier and a catalog number is reproducible only to the extent that the supplier's lots are equivalent, which is precisely the assumption the lot number exists to let a reader check.
Where a project spans more than one lot, note the changeover date. A discontinuity in results that coincides with a lot change is a strong signal, and it is invisible without the record.
Retest dates and shelf life
Peptide material is generally assigned a retest date rather than an expiry date, and the difference is meaningful. An expiry date asserts that the material is unfit afterwards; a retest date says the original analysis should no longer be relied on without re-examination.
A retest date passing does not make material unusable. It means the certificate is no longer current evidence for its condition, and that continued use should rest on either fresh analysis or a judgment about storage history that is explicitly made rather than assumed.